Automated Pulverisette 2 Mortar Mill grinds in double quick time

Published: 22-Feb-2010
Manufacturing

The Automated Pulverisette 2 Mortar Mill from Fritsch is essential for grinding pharmaceutical tablets, pastilles or dragees for further analysis in double quick time.

The Automated Pulverisette 2 Mortar Mill from Fritsch is essential for grinding pharmaceutical tablets, pastilles or dragees for further analysis in double quick time. Reproducible, loss-free fine grinding is achieved through pressure and friction with zero heat generation through to the sample. The illuminated grinding chamber also has a digital timer for ease of use. A wide choice of interchangeable grinding sets is available, which are both easy to remove and clean. Available from: C. Gerhardt UK Ltd, the exclusive Fritsch distributor for UK and Ireland. Visit www.cgerhardt.com or telephone 01280 706772 for further information.
See more

You may also like

Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

Read more
A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline

Trending Articles

  1. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients portfolio, citing rising energy and raw material costs
  2. Romaco Holding appoint Chief Sales Officer Nicola Magriotis will be responsible for the sales and service organisation of the international Romaco Group
  3. ImmuneOncia Therapeutics and Lonza collaborate to manufacture Danburstotug Lonza to support development and manufacturing of ImmuneOncia’s Danburstotug with a complete and integrated end-to-end drug substance and drug product solution
  4. ROIS CDMO closes on the acquisition of US Injectable Manufacturing Facility This strategic move establishes ROIS as a global Contract Development and Manufacturing Organisation (CDMO), expanding from its existing European operations to now offer US-based sterile production
  5. Prange Pharma acquires MSD Animal Health's Italian site to launch Aprilia Animal Health as European veterinary CDMO German pharma company Prange Pharma has completed the acquisition of MSD Animal Health's manufacturing facility in Aprilia, Italy, relaunching it as Aprilia Animal Health to serve as a dedicated European contract manufacturing platform for the veterinary pharmaceuticals sector

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Manufacturing

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Manufacturing

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production
Manufacturing

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
Manufacturing

Symbiosis completes full ICH climatic zone coverage with new stability chamber addition

Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets
Manufacturing

Simplifying continuous operations: lowering the barrier to faster development

Continuous manufacturing has long promised faster development, improved process understanding and, in the absence of scale-up, smoother commercialization. For many pharmaceutical R&D teams, those benefits are well understood. What still holds them back, however, is not scepticism about the concept; it’s the perceived effort required to implement it
Subscribe now